Recommendations for the use of dual-stain cytology with CINtec® PLUS cytology were developed by the American Society for Colposcopy and Cervical Pathology (ASCCP) Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.

CINtec PLUS cytology is the only FDA approved dual-stain biomarker test available and is run on the same cervical sample collected by a clinician during the HPV/Pap screening visit.

Incorporating CINtec PLUS Cytology into your cervical cancer screening journey empowers you to:

• KNOW NOW if she needs immediate attention, independent of prior screening history, HPV genotype, or vaccination status
• Identify more disease than Pap cytology
• Provide the most appropriate management according to risk-based guidelines: immediate intervention with colposcopy or scheduled follow-up

Having the right answers, RIGHT NOW, can change her life.